Perrigo Company plc
corporate_fare Company Profile
Perrigo Company plc (NYSE:PRGO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for PRGO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-04, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for PRGO spans 10-Q, 8-K, 8-K/A, DEF 14A.
Recent high-impact activity:
- Perrigo 10-Q Details $351.6M Nine-Month Loss, $332.6M Impairments and $275M-$375M Infant Formula Hit
- Perrigo Cuts 2026 Core EPS Outlook to $2.15-$2.35 on Soft Europe, Flags $275M-$375M Infant Formula Impairment
- Perrigo Cuts 2026 Sales Outlook After Core Sales Slip 1.7%
- Perrigo Posts 20-Cent Loss Per Share in Third Quarter
- Perrigo Offloads Infant Formula Unit to MeridianMade
Financial Snapshot
Short Interest & Short Volume
11.34 days to coverFINRA reported short interest of 24,611,771 shares in PRGO as of the October 30, 2026 settlement, a 1.8% increase from the prior period — about 11.3 days to cover at its recent average daily volume. On November 20, 2026, 62.5% of PRGO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.